Microvascular changes in COPD patients with severe pulmonary hypertension Source: International Congress 2017 – Imaging and lung disease PH Year: 2017
Are there any significant differences in the bacterial carrier of acute exacerbation of severe and very severe COPD according the degree of pulmonary functional impairment? Source: Eur Respir J 2006; 28: Suppl. 50, 32s Year: 2006
Increased arterial remodelling in smokers and mild-moderate COPD patients are indicative of potential early onset of pulmonary hypertension. Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021
Markers of T2-inflammation in patients with severe asthma and concomitant COPD Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020
Smoking induced pulmonary vascular remodelling in patients with mild COPD Source: Eur Respir J 2007; 30: Suppl. 51, 605s Year: 2007
Acute exacerbation is not related to the decline of airway calibre in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 184s Year: 2001
Relationship between pulmonary hypertension (PH) and lung function in severe COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 252s Year: 2001
The study of the damage degree of myocardial coronary blood flow in patients with chronic obstructive pulmonary disease and severe bronchial asthma Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008
Correlation between respiratory muscles function, systemic inflammation and dyspnoea in patients with severe COPD Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009
The link between systemic inflammation and pulmonary hypertension in patients with stable COPD Source: Eur Respir J 2005; 26: Suppl. 49, 53s Year: 2005
Expression of TGFβ-1 and TGFβ-1RII in pulmonary arteries of patients with severe COPD Source: Eur Respir J 2003; 22: Suppl. 45, 392s Year: 2003
Do COPD patients have a pulmonary vascular phenotype? Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously! Year: 2019
The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020
Effect of dupilumab on severe exacerbations in asthma patients with and without lung function improvements Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020
Cellular and structural changes in peripheral airways of subjects with severe COPD Source: Eur Respir J 2001; 18: Suppl. 33, 91s Year: 2001
Impact of moderate and severe exacerbations in severe COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018
Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma Source: ERJ Open Res, 6 (1) 00204-2019; 10.1183/23120541.00204-2019 Year: 2020
Pulmonary volumes change more largely than respiratory flows in COPD patients during severe acute exacerbations Source: Eur Respir J 2005; 26: Suppl. 49, 362s Year: 2005
Distribution of biomarkers in severe asthma and severe uncontrolled asthma Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021
Vascular dysfunction and systemic inflammation in patients with COPD Source: Annual Congress 2011 - COPD: human studies Year: 2011